Curtis H.

• Led strategic sales efforts in Cell and Gene Therapy, Pharma, and Academia sectors, resulting in revenue growth exceeding $12M annually. • Collaborated with Marketing to implement targeted campaigns for increased brand visibility. • Achieved market penetration and performance improvements, leading to a significant revenue increase for Lonza.

• Collaborate with the sales organization to support and drive the successful sale of the Lonza Bioscience product catalog, ensuring alignment with customer needs and business objectives. • Lead customer demonstrations, deliver product training sessions, and provide technical presentations to support sales efforts and enhance customer understanding of product features and benefits. • Lead and drive key business improvement projects, focusing on process optimization and enhancing operational efficiency across departments.

• Built and nurtured strong relationships with key researchers in the assigned territory, fostering collaboration and driving business growth. • Promote Lonza's portfolio of capital equipment, primary cells, media, and QC testing solutions to academic, biotechnology, and pharmaceutical markets, driving product adoption and expanding market share.

• Managed and developed a team of 5 Account Managers in a newly established region, driving regional sales growth and ensuring alignment with company goals • Developed and implemented innovative sales tactics to navigate significant market changes, ensuring continued growth and competitive advantage

• Led and managed a team of 8 Sales Representatives across the Western U.S. market, driving regional sales performance and fostering a high-performance sales culture. • Collaborated with distribution management to develop and implement programs aimed at boosting sales of Alere products through the distribution channel, while increasing engagement and "ride time" with distribution representatives.

• Managed the sales of Alere's portfolio, including capital equipment, single-use diagnostic kits, and reagents, targeting the point-of-care and hospital markets to drive adoption and revenue growth.